Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

Patent 8383365 was granted and assigned to Ambrx on February, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Patent abstract

Modified FGF-21 polypeptides and uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo